TRxADE GROUP, INC. REPORTS 2019 RESULTS
March 30, 2020 08:05 ET
|
Trxade Group, Inc.
Delivered 2019 annual revenues of $7.43 Million (94.1% increase)Total Adjusted EBITDA of $852,647 (249% increase)Launched next generation of Telehealth Platform ( www.Bonumhealth.com ) Launched Drug...
TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters
February 24, 2020 08:00 ET
|
Trxade Group, Inc.
TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
TRxADE GROUP, INC. Announces Closing of Firm Commitment Common Stock Offering
February 18, 2020 15:50 ET
|
Trxade Group, Inc.
TAMPA, FL, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split
February 13, 2020 09:10 ET
|
Trxade Group, Inc.
Ticker Symbol Change to “MEDS” TAMPA, FL, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS) (OTCQB: TRXD) (“Trxade Group” or the “Company”), an integrated drug procurement,...